Cancer Chemotherapy and Pharmacology

Papers
(The H4-Index of Cancer Chemotherapy and Pharmacology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Tumor microenvironment promotes breast cancer chemoresistance155
Disulfiram: a novel repurposed drug for cancer therapy85
Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells71
Artemisinin-type drugs for the treatment of hematological malignancies41
The role of the glutamine transporter ASCT2 in antineoplastic therapy30
Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway25
Long non-coding RNAs: controversial roles in drug resistance of solid tumors mediated by autophagy23
Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE)22
Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway22
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer22
EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer21
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases21
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug–drug interaction predictions using a PBPK approach21
Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2/M cell cycle arrest, apoptosis, and autophagy19
Panobinostat penetrates the blood–brain barrier and achieves effective brain concentrations in a murine model19
Human placental extract ameliorates methotrexate-induced hepatotoxicity in rats via regulating antioxidative and anti-inflammatory responses18
FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway18
Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever18
Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance18
0.53395891189575